Market revenue in 2023 | USD 17,506.3 million |
Market revenue in 2030 | USD 41,468.7 million |
Growth rate | 13.1% (CAGR from 2023 to 2030) |
Largest segment | Nicotine replacement therapy |
Fastest growing segment | Nicotine Replacement Therapy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nicotine Replacement Therapy |
Key market players worldwide | Cipla Ltd DR, Pfizer Inc, Philip Morris International Inc, British American Tobacco, Japan Tobacco Inc, Imperial Brands PLC, Johnson & Johnson |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nicotine replacement therapy market will help companies and investors design strategic landscapes.
Nicotine replacement therapy was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America nicotine replacement therapy market based on nicotine replacement therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Growth of NRT market in North America can be attributed to various factors, including the growing burden of diseases associated with smoking and the increase in number of favorable government initiatives. Moreover, increasing adoption of e-cigarettes and heated tobacco products is expected to positively impact North America’s nicotine replacement therapy market.
The major tobacco companies in North America are focusing on product launches. Two of the major players operating in this market are GlaxoSmithKline plc. and Philip Morris Products S.A. The local presence globally leading companies is expected to increase the availability of alternatives in the region.
The presence of highly influential regulatory entities in North American countries is expected to foster the development of novel treatments in the near future. This is mainly due to the fact that these entities play a pivotal role in creating awareness among the people about the potential of treatments and supportive care in the management of smoking cessation.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America nicotine replacement therapy market , including forecasts for subscribers. This continent databook contains high-level insights into North America nicotine replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account